These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9244426)

  • 1. Increased incidence of CMV infection after allogeneic bone marrow transplantation from unrelated donors but doubts about an increase in CMV-associated disease.
    de la Cámara R; Fernández-Rañada JM
    Bone Marrow Transplant; 1997 Jul; 20(2):181. PubMed ID: 9244426
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors. The Fukuoka Bone Marrow Transplantation Group.
    Takenaka K; Gondo H; Tanimoto K; Nagafuji K; Fujisaki T; Mizuno S; Miyamoto T; Okamura T; Hayashi S; Eto T; Osaki K; Yamasaki K; Shibuya T; Harada N; Teshima T; Matsuishi E; Minematsu T; Minamishima Y; Harada M; Niho Y
    Bone Marrow Transplant; 1997 Feb; 19(3):241-8. PubMed ID: 9028553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation.
    Shigematsu A; Yasumoto A; Yamamoto S; Sugita J; Kondo T; Onozawa M; Kahata K; Endo T; Ota S; Sato N; Takahata M; Okada K; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):679-85. PubMed ID: 19450752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced risk of persisting cytomegalovirus pp65 antigenemia and cytomegalovirus interstitial pneumonia following allogeneic PBSCT.
    Trenschel R; Ross S; Hüsing J; Ottinger H; Elmaagacli A; Roggendorf M; Schaefer UW; Runde V
    Bone Marrow Transplant; 2000 Mar; 25(6):665-72. PubMed ID: 10734302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in the prevention of cytomegalovirus infection after allogeneic bone marrow transplantation.
    Devergie A; Traineau R; Esperou-Bourdeau H; Ribaud P; Socié G; Richard P; Selimi F; Hirsch I; Gluckman E
    Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S89-90. PubMed ID: 8177726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
    Lamparelli T; Van Lint MT; Gualandi F; Occhini D; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Ferrara GB; Delfino L; Pozzi S; Morabito A; Zikos P; Vitale V; Corvo R; Frassoni F; Bacigalupo A
    Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum cytokines are associated with cytomegalovirus infection and disease in bone marrow transplant recipients.
    Humar A; St Louis P; Mazzulli T; McGeer A; Lipton J; Messner H; MacDonald KS
    J Infect Dis; 1999 Feb; 179(2):484-8. PubMed ID: 9878035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus and adenovirus infections and diseases among 75 paediatric unrelated allogeneic bone marrow transplant recipients.
    Morfin F; Boucher A; Najioullah F; Bertrand Y; Bleyzac N; Poitevin-Later F; Bienvenu F; Simonet V; Galambrun C; Philippe N; Aymard M; Thouvenot D; Souillet G
    J Med Virol; 2004 Feb; 72(2):257-62. PubMed ID: 14695667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation.
    Burns LJ; Miller W; Kandaswamy C; DeFor TE; MacMillan ML; Van Burik JA; Weisdorf DJ
    Bone Marrow Transplant; 2002 Dec; 30(12):945-51. PubMed ID: 12476289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CMV monitoring after peripheral blood stem cell and bone marrow transplantation by pp65 antigen and quantitative PCR.
    Schulenburg A; Watkins-Riedel T; Greinix HT; Rabitsch W; Loidolt H; Keil F; Mitterbauer M; Kalhs P
    Bone Marrow Transplant; 2001 Oct; 28(8):765-8. PubMed ID: 11781628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
    Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
    Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus infection after bone marrow transplantation in children.
    Castagnola E; Cappelli B; Erba D; Rabagliati A; Lanino E; Dini G
    Hum Immunol; 2004 May; 65(5):416-22. PubMed ID: 15172440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognosis value of the pp65 antigenemia and semi-quantitative PCR in the detection of the CMV reactivation in bone marrow grafted patients].
    Ksouri H; Lakhal A; Ben Amor R; Torjman L; Achour W; Ben Othmen T; Ladeb S; Abdelkefi A; Slim A; Abdeladhim A; Ben Hassen A
    Bull Soc Pathol Exot; 2006 Jul; 99(3):155-9. PubMed ID: 16983816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance of cytomegalovirus infections in bone marrow transplant in Trieste: seven years' experience.
    D'Agaro P; Andolina M; Burgnich P; Samar E; Campello C
    Haematologica; 2000 Nov; 85(11 Suppl):54-7. PubMed ID: 11268325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources.
    Walker CM; van Burik JA; De For TE; Weisdorf DJ
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1106-15. PubMed ID: 17697973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay, the amplicor CMV test, and a semi-quantitative polymerase chain reaction test after allogeneic marrow transplantation.
    Ksouri H; Eljed H; Greco A; Lakhal A; Torjman L; Abdelkefi A; Ben Othmen T; Ladeb S; Slim A; Zouari B; Abdeladhim A; Ben Hassen A
    Transpl Infect Dis; 2007 Mar; 9(1):16-21. PubMed ID: 17313466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for cytomegalovirus (CMV) infection in allogeneic bone marrow transplantation using a quantitative whole blood polymerase chain reaction (PCR) method: analysis of potential risk factors for CMV infection.
    Qamruddin AO; Oppenheim BA; Guiver M; Mutton KJ; Chopra R
    Bone Marrow Transplant; 2001 Feb; 27(3):301-6. PubMed ID: 11277178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of cytomegalovirus serostatus on outcome of unrelated cord blood transplantation for adults: a single-institute experience in Japan.
    Tomonari A; Takahashi S; Ooi J; Tsukada N; Konuma T; Kato S; Kasahara S; Iseki T; Yamaguchi T; Tojo A; Asano S
    Eur J Haematol; 2008 Mar; 80(3):251-7. PubMed ID: 18081702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early treatment of CMV antigenemia with ganciclovir for prevention of fatal CMV disease in patients receiving marrow from HLA-matched unrelated donors.
    Shimokawa T; Morishima Y; Kitaori K; Kato C; Sao H
    Int J Hematol; 1999 Aug; 70(2):119-26. PubMed ID: 10497851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk-adapted pre-emptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantation.
    Mori T; Okamoto S; Matsuoka S; Yajima T; Wakui M; Watanabe R; Ishida A; Iwao Y; Mukai M; Hibi T; Ikeda Y
    Bone Marrow Transplant; 2000 Apr; 25(7):765-9. PubMed ID: 10745263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.